Here, CD24+CD38+ Bregs promote tumour progression through a mechanism involving CD40 and CD40L interactions with cancer cells that subsequently leads to the secretion of IL-10 and TGFβ that sustain tumour proliferation [31]. This evidence concerns the gene CD38 and cancer.